Podcasts

Tune into this episode discussing the management of post-stroke spasticity to improve patient outcomes by recognising, diagnosing, and…

In this practical, case-based discussion, a breast oncology pharmacist and nurse practitioner walk through how they anticipate and…

Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood…

How do urologists, oncologists, and advanced practice providers coordinate care in muscle-invasive bladder cancer…

Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the…

Nuclear medicine has undergone extraordinary transformation over the past decades, and it continues to redefine how cancer is diagnosed and…

In this series, host Catherine Glass speaks with Lalith Wijedoru, founder of Behind Your Mask, London, UK, about why social connection is…

In this latest episode of Hema Now, we go behind the scenes of the EAHAD 2026 Congress, exploring how the programme is developed, key emerging priorities, and what lies ahead for haemophilia care in Europe.

Explore innovations shaping liver transplantation, from stem cell science and bioengineered tissues to leadership, equity, and translating discovery into clinical care.

Kenneth Anderson, leading haematology expert at Dana-Farber, shares insights on multiple myeloma, drug resistance, key ASH updates, and turning…

Chronic pain, particularly in the context of rheumatic diseases, represents one of the most pervasive global health challenges, affecting…

In this series, host Saranya Ravindran speaks with Stuart Elborn about translating science into practice. They explore pivotal CF trials, novel and…

Rob Jones of the University of Glasgow shares insights on clinical trial innovation, emerging cancer treatments, and the challenges of managing toxicity in oncology care.

In this series, host Catherine Glass speaks with Michael Byrne about the rise of AI in endoscopy, tackling bias, and redefining clinical trials.

In this special countdown episode, the EMJ Podcast team looks back at the 10 highest-performing episodes of 2025. Spanning neurology…

In this special two-part episode of Onc Now, Catherine Glass returns to take you through the incredible lineup of guests from 2025.

In this series, host Saranya is joined by Nicholas Simmonds to explore the evolving landscape of cystic fibrosis in adulthood.

In this special two-part Onc Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global oncology clinicians and researchers.

David Heymann, global health leader and professor of infectious disease epidemiology, shares lessons from Ebola, SARS, smallpox, and the future of pandemic preparedness.

In this special two-part Hema Now episode, Catherine Glass highlights 2025’s guests, from congress leaders to pioneering, leading global hematology clinicians and researchers.

In this series, host Saranya Ravindran speaks with Lisa Saiman about the global threat of microbial infection and resistance in patients with cystic fibrosis.

Anna Minchom, Clinical Scientist in the Drug Development Unit at the Royal Marsden Hospital, explains the drug development process, key considerations in designing and conducting a trial, and the challenges in drug resistance.

In this series, host Catherine Glass speaks with Katharine Phillips to explore body dysmorphic disorder beyond the skin.

Join Alessandra Gennari and Ana-Tecic-Vuger as they discuss 2 case presentations, firstly a woman with early HR+/HER2- breast Cancer and…